الصفحة الرئيسية>>Signaling Pathways>> Cardiovascular>> Thrombosis>>Clopidogrel Carboxylic Acid (hydrochloride)

Clopidogrel Carboxylic Acid (hydrochloride) (Synonyms: SR26334)

رقم الكتالوجGC43281

Clopidogrel is an antithrombic compound whose active metabolite is a selective, irreversible antagonist of the platelet purinergic P2Y12 receptor (IC50 = 100 nM).

Products are for research use only. Not for human use. We do not sell to patients.

Clopidogrel Carboxylic Acid (hydrochloride) التركيب الكيميائي

Cas No.: 144750-42-5

الحجم السعر المخزون الكميّة
500μg
67٫00
متوفر
1mg
127٫00
متوفر
5mg
535٫00
متوفر
10mg
936٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Clopidogrel is an antithrombic compound whose active metabolite is a selective, irreversible antagonist of the platelet purinergic P2Y12 receptor (IC50 = 100 nM). Clopidogrel inhibits ADP-induced platelet aggregation ex vivo and functions as a prodrug whereupon biotransformation to its active thiol metabolite via CYP2C19 in the liver enables its anti-aggregating activity. An estimated 15% of administered clopidogrel is metabolized by CYP2C19 to the thiol metabolite. Clopidogrel carboxylic acid is a major inactive metabolite of clopidogrel. Most (85%) of circulating clopidogrel is hydrolyzed by esterases to this carboxylic acid form. This inactive metabolite can be used as a reference standard for quantitative analysis of clopidogrel metabolism.

مراجعات

Review for Clopidogrel Carboxylic Acid (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Clopidogrel Carboxylic Acid (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.